Navigation Links
MD Anderson honors 2 champions for women in medicine and research

HOUSTON -- Two champions of gender equality in medicine and research will be honored by The University of Texas MD Anderson Cancer Center at 4 p.m., today in MD Anderson's Onstead Auditorium.

Laurie Glimcher, M.D., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and provost for medical affairs of Cornell University since 2012, will receive the 2014 Margaret L. Kripke Legend Award. She will speak about endoplasmic reticulum stressors in disease.

Thomas Burke, M.D., executive vice president of MD Anderson Cancer Network, will be honored with the President's Leadership Award for Advancing Women Faculty. His remarks will address gender inclusiveness.

Glimcher is noted immunologist, advocate

Glimcher joined Weill Cornell from Harvard, where she was one of the first women professors awarded tenure. She is a renowned immunologist. Her primary research interests are molecular pathways that regulate CD4T helper cell development and activation, work that has led to important advancements in understanding immune function.

As president of the American Association of Immunologists, she founded the Primary Caregivers Technical Assistance Programs, known as the Glimcher Initiative, at the National Institutes of Health (NIH). The program, which she also helped establish at Harvard, supports postdoctoral women scientists with child care responsibilities by providing additional funds for laboratory assistance. Under Glimcher's leadership, Weill Cornell opened an on-site child care center last year.

"I am thrilled and deeply humbled to be the 2014 recipient of the Margaret L. Kripke Legend Award," Glimcher said. "I've dedicated my career to supporting and recognizing women physicians and scientists so they can not only succeed, but go farther than they ever thought they could. I'm proud of the progress we've made in nurturing women leaders in the biomedical sciences and excited for what we can accomplish in the future."

The Kripke Award recognizes a person who has made significant contributions to the advancement and promotion of women in cancer medicine and cancer science. It was established in 2008 by Women Faculty Programs to honor Professor Emerita Margaret L. Kripke, Ph.D., for her unwavering advocacy for and promotion of women in academic medicine and science.

The award is supported by The Vivian L. Smith Foundation, the estate of Elizabeth P. Scott and Polo on the Prairie, a U.S. Polo Association-sanctioned event, on a pasture-turned-polo-field in West Texas, that's one of MD Anderson's longest-running and most popular annual fundraising events.

Kripke, a distinguished scientist, achieved many firsts for women at MD Anderson, culminating in her promotion to executive vice president and chief academic officer. She recently was appointed chief scientific officer of the Cancer Prevention and Research Institute of Texas.

"This is the second year in a row the Kripke Legend Award is being made to a woman who is dean of a major U.S. medical school," said Elizabeth Travis, Ph.D., MD Anderson associate vice president of Women Faculty Programs. "Laurie Glimcher is one of the 23 women who have reached the highest level of leadership in academic medicine. She is an outstanding cancer medicine researcher and teacher, as well as a longstanding advocate of women, and we are thrilled to have her as the awardee."

Burke works to ensure equal opportunities

Burke joined the faculty of MD Anderson in 1988 and was appointed professor in 1998. In 2007, he was named executive vice president and physician-in-chief, an appointment he held through 2013 when he was named executive vice president, MD Anderson Cancer Network.

As the physician in charge of clinical operations, Burke used his position to identify and promote women faculty to medical director positions. He has mentored many woman faculty, created opportunities and helped prepare women for leadership positions through special assignments.

Burke is a practicing gynecologic oncology surgeon whose clinical and research work focuses on vulvar and endometrial cancers.

"I have benefited from the wisdom and guidance of many wonderful mentors throughout my education and career," Burke said. "Several of them were talented women. I am thrilled to be recognized for fostering the professional development of friends and colleagues over the past 25 years at MD Anderson."

The President's Leadership Award for Advancing Women Faculty was initiated last year to recognize the contributions of an MD Anderson faculty member who has had a significant impact on the career advancement of women faculty. Recipients provide vision and leadership to address practices that inadvertently disadvantage women faculty and serve as change agents by creating an environment where women can flourish and advance to leadership positions.

"I am delighted to honor and recognize two individuals who advocate above and beyond the expected for the career advancement of women faculty," said Ronald DePinho, M.D, president of MD Anderson. "Recipients of both awards are chosen based on demonstrating, through their words and actions, a deep personal and professional commitment to this value."


Contact: Scott Merville
University of Texas M. D. Anderson Cancer Center

Related medicine news :

1. UT MD Anderson study finds cancer related pain often undertreated
2. University of Houston Graduate College of Social Work announces partnership with MD Anderson
3. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
4. UT MD Anderson study finds link between depressive symptoms and cancer survival
5. UT MD Anderson Cancer Center launches unprecedented Moon Shots Program
6. UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer
7. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
8. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
9. UT MD Anderson scientists find protein that reins in runaway network
10. MD Anderson study finds qigong improves quality of life for breast cancer patients
11. Leading National Law Firm Anderson Kill & Olick Concludes NRRA Not Intended to Apply to Captive Insurance Companies
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology: